These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 10123838

  • 21. Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial.
    Weinberg WG.
    South Med J; 1993 Aug; 86(8):891-7. PubMed ID: 8351549
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A.
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [Abstract] [Full Text] [Related]

  • 23. [New therapeutic strategies with teicoplanin].
    Carbone E, Nacinovich F, Stamboulian D.
    Medicina (B Aires); 2002 Sep; 62 Suppl 2():25-9. PubMed ID: 12481485
    [Abstract] [Full Text] [Related]

  • 24. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.
    Upton A, Ellis-Pegler RB, Woodhouse A.
    N Z Med J; 2004 Aug 20; 117(1200):U1020. PubMed ID: 15475990
    [Abstract] [Full Text] [Related]

  • 25. Linezolid for the treatment of adults with bone and joint infections.
    Falagas ME, Siempos II, Papagelopoulos PJ, Vardakas KZ.
    Int J Antimicrob Agents; 2007 Mar 20; 29(3):233-9. PubMed ID: 17204407
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana.
    Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, Kenyon T.
    Int J Tuberc Lung Dis; 2003 Sep 20; 7(9 Suppl 1):S80-5. PubMed ID: 12971658
    [Abstract] [Full Text] [Related]

  • 27. Pharmacy department costs and patient charges associated with a home parenteral nutrition program.
    Brakebill JI, Robb RA, Ivey MF, Christensen DB, Young JH, Scribner BH.
    Am J Hosp Pharm; 1983 Feb 20; 40(2):260-3. PubMed ID: 6402929
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness issues for home i.v. therapy in the United States.
    Allen R.
    Hosp Formul; 1993 Jan 20; 28 Suppl 1():37-40. PubMed ID: 10123837
    [Abstract] [Full Text] [Related]

  • 29. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
    Rodger MA, Gagné-Rodger C, Howley HE, Carrier M, Coyle D, Wells PS.
    Thromb Res; 2003 Jan 20; 112(1-2):13-8. PubMed ID: 15013267
    [Abstract] [Full Text] [Related]

  • 30. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
    Brink AJ, Richards GA, Cummins RR, Lambson J, Gauteng Understanding Teicoplanin Serum levels (GUTS) study group.
    Int J Antimicrob Agents; 2008 Nov 20; 32(5):455-8. PubMed ID: 18718742
    [Abstract] [Full Text] [Related]

  • 31. [Vancomycin and teicoplanin use as antibiotic prophylaxis in cardiac surgery: pharmacoeconomic study].
    Codina C, Miró JM, Tuset M, Claramonte J, Gomar C, Gotsens R, Gómez B, Suárez S, Abellana R, Ascaso C, Cartaña R, Rodríguez E, Asenjo M, Carné X, Trilla A, Marco F, Gómez J, Brunet M, Pomar JL, Gatell JM, Ribas J.
    Med Clin (Barc); 2000 Nov 20; 114 Suppl 3():54-61. PubMed ID: 10994565
    [Abstract] [Full Text] [Related]

  • 32. Teicoplanin in the therapy of gram-positive infections: an open non-randomized study.
    De Lalla F, Rinaldi E, Santoro D, Rizzardini G, Martello P, Guaglianone MH.
    J Chemother; 1989 Jul 20; 1(4 Suppl):719-21. PubMed ID: 16312606
    [No Abstract] [Full Text] [Related]

  • 33. Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.
    Spencer CM, Bryson HM.
    Pharmacoeconomics; 1995 Apr 20; 7(4):357-74. PubMed ID: 10155323
    [Abstract] [Full Text] [Related]

  • 34. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC, Mercier RC, Achusim LE, Pai MP.
    Ann Pharmacother; 2004 Jun 20; 38(6):936-41. PubMed ID: 15084688
    [Abstract] [Full Text] [Related]

  • 35. Use of teicoplanin in community medicine.
    Wilson AP, Grüneberg RN.
    Eur J Clin Microbiol Infect Dis; 1994 Sep 20; 13(9):701-10. PubMed ID: 7843174
    [Abstract] [Full Text] [Related]

  • 36. Iv antibiotic therapy in an outpatient setting: report of a joint venture program.
    Eron LJ.
    Hosp Formul; 1988 May 20; 23(5):440-2, 447. PubMed ID: 10312485
    [Abstract] [Full Text] [Related]

  • 37. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C, Fisher DA, Sklar GE, Li SC.
    Int J Antimicrob Agents; 2009 Jan 20; 33(1):46-51. PubMed ID: 18823759
    [Abstract] [Full Text] [Related]

  • 38. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].
    Debbag R, Paganini H, Gómez S, Casimir L, Stamboulian D.
    Medicina (B Aires); 2002 Jan 20; 62 Suppl 2():48-51. PubMed ID: 12481489
    [Abstract] [Full Text] [Related]

  • 39. Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital.
    Sancar AA, Yegenoglu S, de Vries R, Postma MJ, Simsek N, Pechlivanoglou P, Unal S.
    Pharm World Sci; 2008 Dec 20; 30(6):916-23. PubMed ID: 18803030
    [Abstract] [Full Text] [Related]

  • 40. Cost-minimisation analysis of vaginal wall repair in an inpatient or outpatient regimen.
    Sørensen J, Axelsen SM.
    Acta Obstet Gynecol Scand; 2007 Dec 20; 86(4):473-9. PubMed ID: 17486471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.